Acadian Asset Management’s TuHURA Biosciences HURA Stock Holding History

Acadian Asset Management’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	20	–	–	﹤0.01%	2302
2026 Q1	$0	Hold	20	–	–	﹤0.01%	2288
2025 Q4	$0	Buy	20 +9	+82%	+$17	﹤0.01%	2152
2025 Q3	$0	Hold	11	–	–	﹤0.01%	2044
2025 Q2	$0	Hold	11	–	–	﹤0.01%	1870
2025 Q1	$0	Buy	11 +1	+10%	+$4	﹤0.01%	1842
2024 Q4	$0	Hold	10	–	–	﹤0.01%	2244
2024 Q3	$0	Hold	10	–	–	﹤0.01%	2388
2024 Q2	$0	Hold	10	–	–	﹤0.01%	1922
2024 Q1	$0	Sell	10 -3,641	-100%	-$14.6K	﹤0.01%	1823
2023 Q4	$21K	Buy	3,651 +3,466	+1,874%	+$179K	﹤0.01%	1586
2023 Q3	$25K	Hold	185	–	–	﹤0.01%	1512
2023 Q2	$25K	Hold	185	–	–	﹤0.01%	1618
2023 Q1	$22K	Hold	185	–	–	﹤0.01%	1644
2022 Q4	$44K	Sell	185 -127	-41%	-$28.2K	﹤0.01%	1594
2022 Q3	$57K	Buy	312 +194	+164%	+$62K	﹤0.01%	1479
2022 Q2	$58K	Buy	+118	New	+$51.4K	﹤0.01%	1471

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management's HURA Position: Q2 2026 in Review

Acadian Asset Management held its TuHURA Biosciences (HURA) position steady in Q2 2026 at 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Acadian Asset Management first reported a position in HURA in Q2 2022 and has held it in 17 quarters since. The position peaked at $58K in Q2 2022. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Acadian Asset Management held 20 shares of TuHURA Biosciences worth $0 as of Q2 2026.
Acadian Asset Management left its TuHURA Biosciences share count unchanged in Q2 2026.
TuHURA Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #2302 holding.
Acadian Asset Management first reported a position in TuHURA Biosciences in Q2 2022 and has held it in 17 quarters since.
Acadian Asset Management's TuHURA Biosciences position peaked at $58K in Q2 2022.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.